$Delta Air Lines (DAL.US)$+2% (The airline projected "record advance bookings for the summer." It expects sales in the current quarter to increase by 15% to 17% over last year, topping Refinitiv estimates of 14.7%. Delta forecasted adjusted earnings per share of between $2 and $2.25, versus the $1.66 expected by analysts.)
$Merck & Co (MRK.US)$+1% (The company wasupgraded by Citi to buy from neutral, saying its drug pipeline is underappreciated. The Wall Street firm boosted the stock's price target to $130, which implies 14% upside from Wednesday's closing price.)
$NOVO NORDISK A/S (NONOF.US)$+2% (The maker of diabetes and weight loss drugs Ozempic and Wegovy moved about 2% higher in the premarket after being upgraded by Credit Suisse to outperform from neutral. The Wall Street firm said growth in the drugs has "significantly outperformed" its expectations.)
$Harley-Davidson (HOG.US)$-4% (UBS said retail declines for the motorcycle maker in the first quarter may be worse than expected. The Wall Street firm said retail sales could be down close to 20% at U.S. dealers.)
Source: Dow Jones, CNBC
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more